A secondary analysis of GBM patients who underwent surgery followed by chemo-radiotherapy showed that MGMT promoter methylation was significantly associated with longer survival in the entire cohort (p = 0.003) and in females (p = 0.008) but again not in males (p = 0.252). This evidence concerns the gene MGMT and glioblastoma.